KHẢO SÁT TỈ LỆ BỆNH LÝ UNG THƯ HUYẾT HỌC Ở PHÒNG KHÁM HUYẾT HỌC GIAI ĐOẠN 2018-2022 TẠI BỆNH VIỆN ĐẠI HỌC Y DƯỢC THÀNH PHỐ HỒ CHÍ MINH

Abstract

Background: Hematologic cancers are among the most common types of malignancies. Understanding their incidence and progression trends is crucial for prevention, improving clinical practice, and allocating research resources appropriately. Notably, the epidemiological profile of hematologic malignancies at the University Medical Center Ho Chi Minh City (UMC HCMC) differs from that of specialized hematology hospitals. Objectives: To investigate the prevalence and five-year trend of hematologic cancers at the hematology outpatient clinic of UMC HCMC from 2018 to 2022. Subjects and methods: A retrospective study was conducted on all medical records of patients who visited the hematology outpatient clinic at UMC HCMC from January 1, 2018, to December 31, 2022. Results: A total of 11299 patient records were reviewed, with 1207 cases diagnosed with hematologic malignancies, accounting for 10.68%. The average patient age was 57,94 ± 15,8 years, with the most common age group being over 60 years old. Males were more frequently affected than females, comprising 51,12% of cases. Most patients resided in Ho Chi Minh City. The most common hematologic malignancy was non-Hodgkin lymphoma, accounting for 39,27% of cases. The prevalence of hematologic cancer among clinic attendees was not significantly affected by the COVID-19 pandemic. Conclusions: The burden of hematologic malignancies increases with age, partially due to population aging.